AzTrials
AzTrials

StressNCT04414371

Tools for Wellbeing COVID-19 National Study of Undergraduate Students

A study testing Yoga in people with Stress and Anxiety, run by Rutgers, The State University of New Jersey at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study evaluates the effectiveness of yoga practices on reducing stress, negative emotion, anxiety, and depression and on increasing positive emotion, wellbeing and resilience. The study uses randomized wait-list control. All U.S. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stress, Anxiety, Depression
What is being tested?
Yoga
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteUnited States
Study dates
20 May 2020to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 or older
  • Enrolled in 4-year universities/colleges in 2020
  • Not graduate in May 2020

Who cannot join

  • Younger than 18
  • Not enrolled in 4-year universities/colleges in 2020
  • Graduate in May 2020

Trial locations and contacts

1 site in 1 country.

Tracy F Chang, Ph.D. contact

2052666477

tracy.chang@rutgers.edu

United States1 site, 1 recruiting
  • Rutgers University

    New Brunswick, New Jersey, 08901

    Tracy F Chang, Ph.D.

    Recruiting

Other trials in United States

About this study

The study evaluates the effectiveness of yoga practices on reducing stress, negative emotion, anxiety, and depression and on increasing positive emotion, wellbeing and resilience. The study uses randomized wait-list control. All U.S. undergraduate students in 4-year universities and colleges age 18 or older are eligible to participate.

Read the detailed description

The purpose of this project is to widely disseminate a system of yoga tools to university students, faculty, and staff internationally to buffer the psychological impact of the COVID-19 pandemic. A recent study finds that stress, anxiety, and depression are the major psychological responses to COVID-19 during the early outbreaks in China (Wang et al., 2020). Globally, universities have closed campuses and moved learning, teaching, and working online with a very short notice. CDC suggests that keeping physically active and meditation are among the key activities to maintain a strong immune system and mental health during quarantine. Studies have documented physical and mental benefits of yoga practices (Balasubramaniam, Telles, \& Doraiswamy, 2013; Brems, 2015; Brunner, Abramovitch, \& Etherton, 2017; Büssing, Michalsen, Telles, Sherman, \& Khalsa, 2012) This project introduces a system of yoga tools to buffer the psychological impact of COVID-19. This system of yoga tools is designed by Sadhguru Jaggi Vasudev, a yogi, mystic, author, and founder of the Isha Foundation. The Isha foundation is a volunteer-based international non-profit organization, offering yoga and meditation programs for human wellbeing and global harmony. In partnership with the Isha Foundation and Harvard University Medical School, the study will document the short-term and long-term effects of these yogic practices on stress, mood, wellbeing, resilience, and academic engagement for students and work engagement for faculty and staff during this challenging time.

Being tested
Yoga
Keywords
yoga stress anxiety depression wellbeing COVID
Medical subject headings
Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • YogaOther

    Yoga Namaskar and Nadi Shuddhi

Study groups in NCT04414371
Study groupRoleWhat they receive
Group 1 - Yoga GroupExperimentalLearn online yoga practices and practice daily for 12-weeks
Receives: Other: Yoga
Group 2 - Control GroupOtherwaist-list control for 4-week, cross-over to yoga practice for 8-week
Receives: Other: Yoga

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stress

    10-item Perceived Stress Scale (PSS), score 0-40, higher the score, higher stress

    Measured: Change from baseline stress at 1-Month

  2. Stress

    10-item Perceived Stress Scale (PSS), score 0-40, higher the score, higher stress

    Measured: Change from baseline stress at 2-Month

  3. Stress

    10-item Perceived Stress Scale (PSS), score 0-40, higher the score, higher stress

    Measured: Change from baseline stress in 3-Month

  4. Wellbeing

    14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

    Measured: Change from baseline wellbeing in 2-week

  5. Wellbeing

    14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

    Measured: Change from baseline wellbeing in 4-week

  6. Wellbeing

    14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

    Measured: Change from baseline wellbeing in 6-week

  7. Wellbeing

    14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

    Measured: Change from baseline wellbeing in 8-week

  8. Wellbeing

    14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

    Measured: Change from baseline wellbeing in 10-week

  9. Wellbeing

    14-item Warwick-Edinburgh Wellbeing Scale (WEMWBS), score14-70, higher score higher wellbeing

    Measured: Change from baseline wellbeing in 12-week

Secondary outcomes (27)
  1. Anxiety

    2-item PHQ-4, score 2-8, higher score higher anxiety

    Measured: Change from baseline anxiety in 2-week

  2. Anxiety

    2-item PHQ-4, score 2-8, higher score higher anxiety

    Measured: Change from baseline anxiety in 4-week

  3. Anxiety

    2-item PHQ-4, score 2-8, higher score higher anxiety

    Measured: Change from baseline anxiety in 6-week

  4. Anxiety

    2-item PHQ-4, score 2-8, higher score higher anxiety

    Measured: Change from baseline anxiety in 8-week

  5. Anxiety

    2-item PHQ-4, score 2-8, higher score higher anxiety

    Measured: Change from baseline anxiety in 10-week

  6. Anxiety

    2-item PHQ-4, score 2-8, higher score higher anxiety

    Measured: Change from baseline anxiety in 12-week

  7. Depression

    2-item PHQ-4, score 2-8, higher score higher depression

    Measured: Change from baseline depression in 2-week

  8. Depression

    2-item PHQ-4, score 2-8, higher score higher depression

    Measured: Change from baseline depression in 4-week

  9. Depression

    2-item PHQ-4, score 2-8, higher score higher depression

    Measured: Change from baseline depression in 6-week

  10. Depression

    2-item PHQ-4, score 2-8, higher score higher depression

    Measured: Change from baseline depression in 8-week

  11. Depression

    2-item PHQ-4, score 2-8, higher score higher depression

    Measured: Change from baseline depression in 10-week

  12. Depression

    2-item PHQ-4, score 2-8, higher score higher depression

    Measured: Change from baseline depression in 12-week

  13. Resilience

    6-item Brief Resilience Scale (BRS), score 6-30, higher score higher resilience

    Measured: Change from baseline resilience in 1-month

  14. Resilience

    6-item Brief Resilience Scale (BRS), score 6-30, higher score higher resilience

    Measured: Change from baseline resilience in 2-month

  15. Resilience

    6-item Brief Resilience Scale (BRS), score 6-30, higher score higher resilience

    Measured: Change from baseline resilience in 3-month

  16. Positive Affect

    10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

    Measured: Change from baseline positive affect in 2-week

  17. Positive Affect

    10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

    Measured: Change from baseline positive affect in 4-week

  18. Positive Affect

    10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

    Measured: Change from baseline positive affect in 6-week

  19. Positive Affect

    10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

    Measured: Change from baseline positive affect in 8-week

  20. Positive Affect

    10-item Positive Affect Scale, score - 10 to 50, higher score more positive affect

    Measured: Change from baseline positive affect in 10-week

  21. Positive Affect

    10-item Positive Affect Scale, score - 10 to 50, higher score higher positive affect

    Measured: Change from baseline positive affect in 12-week

  22. Negative Affect

    10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

    Measured: Change from baseline negative affect in 2-week

  23. Negative Affect

    10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

    Measured: Change from baseline negative affect in 4-week

  24. Negative Affect

    10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

    Measured: Change from baseline negative affect in 6-week

  25. Negative Affect

    10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

    Measured: Change from baseline negative affect in 8-week

  26. Negative Affect

    10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

    Measured: Change from baseline negative affect in 10-week

  27. Negative Affect

    10-item Negative Affect Scale, score - 10 to 50, higher score higher negative affect

    Measured: Change from baseline negative affect in 12-week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2020
  2. Study start20 May 2020
  3. Primary completion31 Dec 2020 (estimated)
  4. Study completion31 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Model description
Randomized waitlist control cross over
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04414371
Sponsor's protocol ID
Pro2020000953
Status last verified
Jun 2020
First submitted
31 May 2020
Last updated
4 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Balasubramaniam M, Telles S, Doraiswamy PM. Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders. Front Psychiatry. 2013 Jan 25;3:117. doi: 10.3389/fpsyt.2012.00117. eCollection 2012.

    PubMed 23355825
  • Brems C. A Yoga Stress Reduction Intervention for University Faculty, Staff, and Graduate Students. Int J Yoga Therap. 2015;25(1):61-77. doi: 10.17761/1531-2054-25.1.61.

    PubMed 26667290
  • Brunner D, Abramovitch A, Etherton J. A yoga program for cognitive enhancement. PLoS One. 2017 Aug 4;12(8):e0182366. doi: 10.1371/journal.pone.0182366. eCollection 2017.

    PubMed 28783749
  • Bussing A, Michalsen A, Khalsa SB, Telles S, Sherman KJ. Effects of yoga on mental and physical health: a short summary of reviews. Evid Based Complement Alternat Med. 2012;2012:165410. doi: 10.1155/2012/165410. Epub 2012 Sep 13.

    PubMed 23008738
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.

    PubMed 6668417
  • Froeliger BE, Garland EL, Modlin LA, McClernon FJ. Neurocognitive correlates of the effects of yoga meditation practice on emotion and cognition: a pilot study. Front Integr Neurosci. 2012 Jul 26;6:48. doi: 10.3389/fnint.2012.00048. eCollection 2012.

    PubMed 22855674
  • Gard T, Noggle JJ, Park CL, Vago DR, Wilson A. Potential self-regulatory mechanisms of yoga for psychological health. Front Hum Neurosci. 2014 Sep 30;8:770. doi: 10.3389/fnhum.2014.00770. eCollection 2014.

    PubMed 25368562
  • Schmalzl L, Powers C, Henje Blom E. Neurophysiological and neurocognitive mechanisms underlying the effects of yoga-based practices: towards a comprehensive theoretical framework. Front Hum Neurosci. 2015 May 8;9:235. doi: 10.3389/fnhum.2015.00235. eCollection 2015.

    PubMed 26005409
  • Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194-200. doi: 10.1080/10705500802222972.

    PubMed 18696313
  • Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, Parkinson J, Secker J, Stewart-Brown S. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007 Nov 27;5:63. doi: 10.1186/1477-7525-5-63.

    PubMed 18042300
  • Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020 Mar 6;17(5):1729. doi: 10.3390/ijerph17051729.

    PubMed 32155789

Questions about this trial

What is this clinical trial studying?

A study testing Yoga in people with Stress and Anxiety, run by Rutgers, The State University of New Jersey at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tracy F Chang, Ph.D. (2052666477, tracy.chang@rutgers.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stress (time frame: Change from baseline stress at 1-Month). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04414371, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in